Research
FORUM TRANSCRIPT

COVID-19 Vaccines Roll-out – Supply & Demand Analysis – 27 November 2020

  • Public Equity
  • Healthcare
  • Europe
PREMIUM

Specialist

Director at Gavi, The Vaccine Alliance

Agenda

  • Availability of supply following US FDA EUA (Food and Drug Administration Emergency Use Authorisation), volume commitment updates and vaccine manufacturers’ ability to scale up supply
  • Review of various go-to-market and vaccine allocation strategies
  • Supply chain capacity, role of centralised or government entities and remaining logistical bottlenecks
  • Timelines for mass-scale immunisation by region and outlook for herd immunity 5. Commercial opportunity for the industry

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo